These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 31609608)

  • 1. Dual-Acting Cholinesterase-Human Cannabinoid Receptor 2 Ligands Show Pronounced Neuroprotection in Vitro and Overadditive and Disease-Modifying Neuroprotective Effects in Vivo.
    Scheiner M; Dolles D; Gunesch S; Hoffmann M; Nabissi M; Marinelli O; Naldi M; Bartolini M; Petralla S; Poeta E; Monti B; Falkeis C; Vieth M; Hübner H; Gmeiner P; Maitra R; Maurice T; Decker M
    J Med Chem; 2019 Oct; 62(20):9078-9102. PubMed ID: 31609608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual-Acting Small Molecules: Subtype-Selective Cannabinoid Receptor 2 Agonist/Butyrylcholinesterase Inhibitor Hybrids Show Neuroprotection in an Alzheimer's Disease Mouse Model.
    Spatz P; Steinmüller SAM; Tutov A; Poeta E; Morilleau A; Carles A; Deventer MH; Hofmann J; Stove CP; Monti B; Maurice T; Decker M
    J Med Chem; 2023 May; 66(9):6414-6435. PubMed ID: 37127287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-Activity Relationships and Computational Investigations into the Development of Potent and Balanced Dual-Acting Butyrylcholinesterase Inhibitors and Human Cannabinoid Receptor 2 Ligands with Pro-Cognitive in Vivo Profiles.
    Dolles D; Hoffmann M; Gunesch S; Marinelli O; Möller J; Santoni G; Chatonnet A; Lohse MJ; Wittmann HJ; Strasser A; Nabissi M; Maurice T; Decker M
    J Med Chem; 2018 Feb; 61(4):1646-1663. PubMed ID: 29400965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Syntheses of coumarin-tacrine hybrids as dual-site acetylcholinesterase inhibitors and their activity against butylcholinesterase, Aβ aggregation, and β-secretase.
    Sun Q; Peng DY; Yang SG; Zhu XL; Yang WC; Yang GF
    Bioorg Med Chem; 2014 Sep; 22(17):4784-91. PubMed ID: 25088549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of novel benzofuran-based compounds with neuroprotective and immunomodulatory properties for Alzheimer's disease treatment.
    Montanari S; Mahmoud AM; Pruccoli L; Rabbito A; Naldi M; Petralla S; Moraleda I; Bartolini M; Monti B; Iriepa I; Belluti F; Gobbi S; Di Marzo V; Bisi A; Tarozzi A; Ligresti A; Rampa A
    Eur J Med Chem; 2019 Sep; 178():243-258. PubMed ID: 31185414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel tacrine-tryptophan hybrids: Multi-target directed ligands as potential treatment for Alzheimer's disease.
    Chalupova K; Korabecny J; Bartolini M; Monti B; Lamba D; Caliandro R; Pesaresi A; Brazzolotto X; Gastellier AJ; Nachon F; Pejchal J; Jarosova M; Hepnarova V; Jun D; Hrabinova M; Dolezal R; Zdarova Karasova J; Mzik M; Kristofikova Z; Misik J; Muckova L; Jost P; Soukup O; Benkova M; Setnicka V; Habartova L; Chvojkova M; Kleteckova L; Vales K; Mezeiova E; Uliassi E; Valis M; Nepovimova E; Bolognesi ML; Kuca K
    Eur J Med Chem; 2019 Apr; 168():491-514. PubMed ID: 30851693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroprotective derivatives of tacrine that target NMDA receptor and acetyl cholinesterase - Design, synthesis and biological evaluation.
    Remya C; Dileep KV; Koti Reddy E; Mantosh K; Lakshmi K; Sarah Jacob R; Sajith AM; Jayadevi Variyar E; Anwar S; Zhang KYJ; Sadasivan C; Omkumar RV
    Comput Struct Biotechnol J; 2021; 19():4517-4537. PubMed ID: 34471497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis and neuroprotective evaluation of novel tacrine-benzothiazole hybrids as multi-targeted compounds against Alzheimer's disease.
    Keri RS; Quintanova C; Marques SM; Esteves AR; Cardoso SM; Santos MA
    Bioorg Med Chem; 2013 Aug; 21(15):4559-69. PubMed ID: 23768661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New Tetrahydroacridine Hybrids with Dichlorobenzoic Acid Moiety Demonstrating Multifunctional Potential for the Treatment of Alzheimer's Disease.
    Czarnecka K; Girek M; Wójtowicz P; Kręcisz P; Skibiński R; Jończyk J; Łątka K; Bajda M; Walczak A; Galita G; Kabziński J; Majsterek I; Szymczyk P; Szymański P
    Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32466601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel multifunctional tacrine-donepezil hybrids against Alzheimer's disease: Design synthesis and bioactivity studies.
    Bayraktar G; Bartolini M; Bolognesi ML; Erdoğan MA; Armağan G; Bayır E; Şendemir A; Bagetta D; Alcaro S; Alptüzün V
    Arch Pharm (Weinheim); 2024 Jul; 357(7):e2300575. PubMed ID: 38593283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis and evaluation of novel tacrine-coumarin hybrids as multifunctional cholinesterase inhibitors against Alzheimer's disease.
    Xie SS; Wang XB; Li JY; Yang L; Kong LY
    Eur J Med Chem; 2013 Jun; 64():540-53. PubMed ID: 23685572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo Biological Evaluation of Newly Tacrine-Selegiline Hybrids as Multi-Target Inhibitors of Cholinesterases and Monoamine Oxidases for Alzheimer's Disease.
    Huang ST; Luo JC; Zhong GH; Teng LP; Yang CY; Tang CL; Jing L; Zhou ZB; Liu J; Jiang N
    Drug Des Devel Ther; 2024; 18():133-159. PubMed ID: 38283137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multifunctional tacrine-flavonoid hybrids with cholinergic, β-amyloid-reducing, and metal chelating properties for the treatment of Alzheimer's disease.
    Li SY; Wang XB; Xie SS; Jiang N; Wang KD; Yao HQ; Sun HB; Kong LY
    Eur J Med Chem; 2013 Nov; 69():632-46. PubMed ID: 24095756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent Developments on Multi-Target-Directed Tacrines for Alzheimer's Disease. I. The Pyranotacrines.
    Romero A; Marco-Contelles J
    Curr Top Med Chem; 2017; 17(31):3328-3335. PubMed ID: 29332586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tetrahydrobenzo[h][1,6]naphthyridine-6-chlorotacrine hybrids as a new family of anti-Alzheimer agents targeting β-amyloid, tau, and cholinesterase pathologies.
    Di Pietro O; Pérez-Areales FJ; Juárez-Jiménez J; Espargaró A; Clos MV; Pérez B; Lavilla R; Sabaté R; Luque FJ; Muñoz-Torrero D
    Eur J Med Chem; 2014 Sep; 84():107-17. PubMed ID: 25016233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, biological evaluation, and molecular modeling simulations of new heterocyclic hybrids as multi-targeted anti-Alzheimer's agents.
    Waly OM; Saad KM; El-Subbagh HI; Bayomi SM; Ghaly MA
    Eur J Med Chem; 2022 Mar; 231():114152. PubMed ID: 35101650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel multipotent phenylthiazole-tacrine hybrids for the inhibition of cholinesterase activity, β-amyloid aggregation and Ca²⁺ overload.
    Wang Y; Wang F; Yu JP; Jiang FC; Guan XL; Wang CM; Li L; Cao H; Li MX; Chen JG
    Bioorg Med Chem; 2012 Nov; 20(21):6513-22. PubMed ID: 23000296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New racemic annulated pyrazolo[1,2-b]phthalazines as tacrine-like AChE inhibitors with potential use in Alzheimer's disease.
    Jalili-Baleh L; Nadri H; Moradi A; Bukhari SNA; Shakibaie M; Jafari M; Golshani M; Homayouni Moghadam F; Firoozpour L; Asadipour A; Emami S; Khoobi M; Foroumadi A
    Eur J Med Chem; 2017 Oct; 139():280-289. PubMed ID: 28803044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Total Synthesis of Pulmonarin B and Design of Brominated Phenylacetic Acid/Tacrine Hybrids: Marine Pharmacophore Inspired Discovery of New ChE and Aβ Aggregation Inhibitors.
    Cheng ZQ; Song JL; Zhu K; Zhang J; Jiang CS; Zhang H
    Mar Drugs; 2018 Aug; 16(9):. PubMed ID: 30134630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of cholinesterase activity and amyloid aggregation by berberine-phenyl-benzoheterocyclic and tacrine-phenyl-benzoheterocyclic hybrids.
    Huang L; Su T; Shan W; Luo Z; Sun Y; He F; Li X
    Bioorg Med Chem; 2012 May; 20(9):3038-48. PubMed ID: 22472046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.